Literature DB >> 18029000

Effect of duration of in vitro maturation on nuclear maturation and fertilizability of feline oocytes.

M Nagano1, K Uchikura, Y Takahashi, M Hishinuma.   

Abstract

This study was conducted to improve in vitro production of embryos from domestic cats using TCM-199 as an IVM medium. The time sequence of nuclear maturation and the optimal timing of in vitro insemination were examined. Most oocytes were at the germinal vesicle stage immediately after collection; however, 8.3% had already resumed meiosis before IVM culture. After 30 h of IVM culture, the percentage of oocytes at metaphase II (MII) reached a peak (75.5%) and did not change (P>0.05) from 30 to 48 h after IVM culture. The percentage of oocytes with two pronuclei was higher (P<0.05) for oocytes matured for 30 and 36 h (38.2 and 33.0%, respectively) than for those after IVM culture for only 24 h (18.5%). Total sperm penetration rate was highest (P<0.05) for oocytes that had been matured for 30 h (46.1%). After 30 h of IVM and 18 h of IVF culture, 66.3 and 24.8% of inseminated oocytes had cleaved and developed to the blastocyst stage, respectively. We concluded that IVM of feline oocytes for 30 h in TCM-199 resulted in optimal nuclear maturation and sperm penetration.

Entities:  

Mesh:

Year:  2007        PMID: 18029000     DOI: 10.1016/j.theriogenology.2007.09.017

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  2 in total

1.  Current State of In Vitro Embryo Production in African Lion (Panthera leo).

Authors:  Jennifer Zahmel; Kim Skalborg Simonsen; Julia Stagegaard; Sergio Eliseo Palma-Vera; Katarina Jewgenow
Journal:  Animals (Basel)       Date:  2022-05-31       Impact factor: 3.231

2.  Feline embryo development in commercially available human media supplemented with fetal bovine serum.

Authors:  Md Emtiaj Alam; Jun Iwata; Kana Fujiki; Yasunori Tsujimoto; Ryoji Kanegi; Noritoshi Kawate; Hiromichi Tamada; Toshio Inaba; Kikuya Sugiura; Shingo Hatoya
Journal:  J Vet Med Sci       Date:  2019-02-19       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.